These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 8254191)
1. Induction of protective immunity to Haemophilus ducreyi in the temperature-dependent rabbit model of experimental chancroid. Hansen EJ; Lumbley SR; Richardson JA; Purcell BK; Stevens MK; Cope LD; Datte J; Radolf JD J Immunol; 1994 Jan; 152(1):184-92. PubMed ID: 8254191 [TBL] [Abstract][Full Text] [Related]
2. Oral immunization using HgbA in a recombinant chancroid vaccine delivered by attenuated Salmonella typhimurium SL3261 in the temperature-dependent rabbit model. Breau C; Cameron DW; Desjardins M; Lee BC J Immunol Methods; 2012 Jan; 375(1-2):232-42. PubMed ID: 22100216 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of humoral and cell-mediated inducible immunity to Haemophilus ducreyi in an animal model of chancroid. Desjardins M; Filion LG; Robertson S; Kobylinski L; Cameron DW Infect Immun; 1996 May; 64(5):1778-88. PubMed ID: 8613391 [TBL] [Abstract][Full Text] [Related]
4. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid. Afonina G; Leduc I; Nepluev I; Jeter C; Routh P; Almond G; Orndorff PE; Hobbs M; Elkins C Infect Immun; 2006 Apr; 74(4):2224-32. PubMed ID: 16552053 [TBL] [Abstract][Full Text] [Related]
5. Experimental infection of human volunteers with Haemophilus ducreyi does not confer protection against subsequent challenge. Al-Tawfiq JA; Palmer KL; Chen CY; Haley JC; Katz BP; Hood AF; Spinola SM J Infect Dis; 1999 May; 179(5):1283-7. PubMed ID: 10191238 [TBL] [Abstract][Full Text] [Related]
6. Antibodies directed against Haemophilus ducreyi heat shock proteins. Brown TJ; Jardine J; Ison CA Microb Pathog; 1993 Aug; 15(2):131-9. PubMed ID: 8255206 [TBL] [Abstract][Full Text] [Related]
7. A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi. Purcell BK; Richardson JA; Radolf JD; Hansen EJ J Infect Dis; 1991 Aug; 164(2):359-67. PubMed ID: 1856485 [TBL] [Abstract][Full Text] [Related]
8. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA with adjuvant monophosphoryl lipid A protects swine from a homologous but not a heterologous challenge. Fusco WG; Afonina G; Nepluev I; Cholon DM; Choudhary N; Routh PA; Almond GW; Orndorff PE; Staats H; Hobbs MM; Leduc I; Elkins C Infect Immun; 2010 Sep; 78(9):3763-72. PubMed ID: 20584974 [TBL] [Abstract][Full Text] [Related]
9. Use of an adsorption enzyme immunoassay to evaluate the Haemophilus ducreyi specific and cross-reactive humoral immune response of humans. Alfa MJ; Olson N; Degagne P; Slaney L; Plummer F; Namaara W; Ronald AR Sex Transm Dis; 1992; 19(6):309-14. PubMed ID: 1492255 [TBL] [Abstract][Full Text] [Related]
10. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi. Frisk A; Ahmed HJ; Van Dyck E; Lagergård T Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686 [TBL] [Abstract][Full Text] [Related]
11. Attenuated Salmonella typhimurium SL3261 as a vaccine vector for recombinant antigen in rabbits. Ashby D; Leduc I; Lauzon W; Lee BC; Singhal N; Cameron DW J Immunol Methods; 2005 Apr; 299(1-2):153-64. PubMed ID: 15914198 [TBL] [Abstract][Full Text] [Related]
12. Passive immunization with a polyclonal antiserum to the hemoglobin receptor of Haemophilus ducreyi confers protection against a homologous challenge in the experimental swine model of chancroid. Leduc I; Fusco WG; Choudhary N; Routh PA; Cholon DM; Hobbs MM; Almond GW; Orndorff PE; Elkins C Infect Immun; 2011 Aug; 79(8):3168-77. PubMed ID: 21646451 [TBL] [Abstract][Full Text] [Related]
13. Inducible immunity with a pilus preparation booster vaccination in an animal model of Haemophilus ducreyi infection and disease. Desjardins M; Filion LG; Robertson S; Cameron DW Infect Immun; 1995 May; 63(5):2012-20. PubMed ID: 7729916 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of skin adherence, penetration and tissue necrosis production by Haemophilus ducreyi, the causative agent of chancroid. Abeck D; Korting HC Acta Derm Venereol Suppl (Stockh); 1992; 174():1-20. PubMed ID: 1636361 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo activity of combination antimicrobial agents on Haemophilus ducreyi. Roy-Leon JE; Lauzon WD; Toye B; Singhal N; Cameron DW J Antimicrob Chemother; 2005 Sep; 56(3):552-8. PubMed ID: 16046468 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of, antibody response to, and immunity induced by Haemophilus ducreyi hemolysin. Dutro SM; Wood GE; Totten PA Infect Immun; 1999 Jul; 67(7):3317-28. PubMed ID: 10377108 [TBL] [Abstract][Full Text] [Related]
19. Use of signature-tagged mutagenesis to identify virulence determinants in Haemophilus ducreyi responsible for ulcer formation. Yeung A; Cameron DW; Desjardins M; Lee BC J Microbiol Methods; 2011 Feb; 84(2):290-8. PubMed ID: 21185881 [TBL] [Abstract][Full Text] [Related]
20. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid. Lagergård T Microb Pathog; 1992 Sep; 13(3):203-17. PubMed ID: 1291843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]